NFKB1 and chronic kidney disease: GSK3β acts as a key regulatory kinase within multiple signaling pathways, including Wnt/β-catenin, NF-κB, Nrf2, TGFβ-Smad, which together orchestrate critical aspects of kidney damage in CKD.